Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balance
Inhibition of hypothalamic nitric oxide (NO) decreases energy intake, and changes in hypothalamic NO synthase (NOS) have been observed in genetically obese rodents, but it is not known if NO is involved in the development of diet-induced obesity (DIO). We therefore measured changes in hypothalamic n...
Gespeichert in:
Veröffentlicht in: | Brain research 2004-08, Vol.1016 (2), p.222-228 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 228 |
---|---|
container_issue | 2 |
container_start_page | 222 |
container_title | Brain research |
container_volume | 1016 |
creator | Sadler, C.J Wilding, J.P.H |
description | Inhibition of hypothalamic nitric oxide (NO) decreases energy intake, and changes in hypothalamic NO synthase (NOS) have been observed in genetically obese rodents, but it is not known if NO is involved in the development of diet-induced obesity (DIO). We therefore measured changes in hypothalamic neuronal NOS (nNOS) in DIO and investigated effects of peripheral and central inhibition of NOS in this model. Expression of nNOS in relation to changes in nutritional state was measured by immunohistochemistry, with radiochemical detection. The effect of chronic intraperitoneal (i.p.) administration of the NOS inhibitor
N
G-nitro-
l-arginine methyl ester (
l-NAME, 50 mg/kg/day) on energy intake, bodyweight and hypothalamic nitric oxide content was assessed in both chow-fed and DIO animals. Twenty-four hour energy intake after acute intracerebroventricular (i.c.v.) of
l-NME was also measured. Diet-induced obese animals had a statistically significant 32% reduction in the number of nNOS-immunolabelled cells in the ventromedial hypothalamus compared to chow-fed controls. Intraperitoneal administration of
l-NAME decreased hypothalamic NO content in both chow-fed and DIO. Energy intake was reduced by 16% in DIO over 16 days, whereas energy intake was only reduced by 11% in chow-fed animals, although both were statistically significant.
l-NAME significantly reduced body weight gain in DIO but not in chow-fed rats.
l-NAME administered i.c.v. decreased 24 h energy intake to a greater extent in DIO rats, by 18%, compared with a 10% reduction in chow-fed rats. Ventromedial hypothalamic expression of nNOS is sensitive to changes in nutritional state. Despite having reduced nNOS, dietary obese rats were more sensitive to the effects of NOS inhibition than lean controls, suggesting a role for NO in the development of hyperphagia and obesity in rats fed a palatable diet. |
doi_str_mv | 10.1016/j.brainres.2004.05.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17820811</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899304007309</els_id><sourcerecordid>17820811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-4a3f86ee1796f1b2222ef34ea33c59767d5838f83959690dd4e6c4426dac15313</originalsourceid><addsrcrecordid>eNqFkU2P0zAQhiMEYsvCX1j5ArcWO04chxNoxZe0YiU-zpZjT7auUruMnWr7O_lDTGkRcMIXe-znnRnPW1VXgq8EF-rlZjWgDREhr2rOmxVvV5x3D6qF0F29VHXDH1YLzrla6r6XF9WTnDcUStnzx9WFaOtG6VYvqh-fwc8OPNtDLJi24IOd2PqwS2VtJ7sNjkWYMUW6jaEgxek-eGD5EInIwGz0LESHQIFnGWIOJexDObCS2KfbL_S4DgPdpUhH5gMUiweWBiAx2pJfsXHGsgZksKfM0QFLI7MM0wRsTPhvXUpBLEO4myf7KynBEAHvDmygjkn-tHo02inDs_N-WX179_br9Yflze37j9dvbpauqduybKwctQIQXa9GMdS0YJQNWCld23eq862WetSyb3vVc-8bUK5pauWtE60U8rJ6ccq7w_R9hlzMNmQHEzUBac5GdLrmWhxBdQIdppwRRrPDsKUpGMHN0U6zMb_tNEc7DW8N2UnCq3OFeSBr_sjO_hHw_AzY7Ow0Iv0_5L-4vm1qLYl7feKA5rEPgCa7cBy1DwiuGJ_C_3r5CSEIxu8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17820811</pqid></control><display><type>article</type><title>Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balance</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sadler, C.J ; Wilding, J.P.H</creator><creatorcontrib>Sadler, C.J ; Wilding, J.P.H</creatorcontrib><description>Inhibition of hypothalamic nitric oxide (NO) decreases energy intake, and changes in hypothalamic NO synthase (NOS) have been observed in genetically obese rodents, but it is not known if NO is involved in the development of diet-induced obesity (DIO). We therefore measured changes in hypothalamic neuronal NOS (nNOS) in DIO and investigated effects of peripheral and central inhibition of NOS in this model. Expression of nNOS in relation to changes in nutritional state was measured by immunohistochemistry, with radiochemical detection. The effect of chronic intraperitoneal (i.p.) administration of the NOS inhibitor
N
G-nitro-
l-arginine methyl ester (
l-NAME, 50 mg/kg/day) on energy intake, bodyweight and hypothalamic nitric oxide content was assessed in both chow-fed and DIO animals. Twenty-four hour energy intake after acute intracerebroventricular (i.c.v.) of
l-NME was also measured. Diet-induced obese animals had a statistically significant 32% reduction in the number of nNOS-immunolabelled cells in the ventromedial hypothalamus compared to chow-fed controls. Intraperitoneal administration of
l-NAME decreased hypothalamic NO content in both chow-fed and DIO. Energy intake was reduced by 16% in DIO over 16 days, whereas energy intake was only reduced by 11% in chow-fed animals, although both were statistically significant.
l-NAME significantly reduced body weight gain in DIO but not in chow-fed rats.
l-NAME administered i.c.v. decreased 24 h energy intake to a greater extent in DIO rats, by 18%, compared with a 10% reduction in chow-fed rats. Ventromedial hypothalamic expression of nNOS is sensitive to changes in nutritional state. Despite having reduced nNOS, dietary obese rats were more sensitive to the effects of NOS inhibition than lean controls, suggesting a role for NO in the development of hyperphagia and obesity in rats fed a palatable diet.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/j.brainres.2004.05.007</identifier><identifier>PMID: 15246858</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Analysis of Variance ; Animals ; Biological and medical sciences ; Body Weight - drug effects ; Cell Count - methods ; Diet ; Energy balance ; Energy Intake - drug effects ; Enzyme Inhibitors - pharmacology ; Hypothalamus ; Immunohistochemistry - methods ; Male ; Medical sciences ; Metabolic diseases ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric oxide ; Nitric Oxide - physiology ; Nitric Oxide Synthase - antagonists & inhibitors ; Nitric Oxide Synthase - metabolism ; Nitric Oxide Synthase Type I ; Obesity ; Obesity - chemically induced ; Obesity - metabolism ; Rats ; Rats, Wistar ; Ventromedial Hypothalamic Nucleus - drug effects ; Ventromedial Hypothalamic Nucleus - enzymology ; Ventromedial Hypothalamic Nucleus - metabolism</subject><ispartof>Brain research, 2004-08, Vol.1016 (2), p.222-228</ispartof><rights>2004 Elsevier B.V.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-4a3f86ee1796f1b2222ef34ea33c59767d5838f83959690dd4e6c4426dac15313</citedby><cites>FETCH-LOGICAL-c425t-4a3f86ee1796f1b2222ef34ea33c59767d5838f83959690dd4e6c4426dac15313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.brainres.2004.05.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15954283$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15246858$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sadler, C.J</creatorcontrib><creatorcontrib>Wilding, J.P.H</creatorcontrib><title>Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balance</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Inhibition of hypothalamic nitric oxide (NO) decreases energy intake, and changes in hypothalamic NO synthase (NOS) have been observed in genetically obese rodents, but it is not known if NO is involved in the development of diet-induced obesity (DIO). We therefore measured changes in hypothalamic neuronal NOS (nNOS) in DIO and investigated effects of peripheral and central inhibition of NOS in this model. Expression of nNOS in relation to changes in nutritional state was measured by immunohistochemistry, with radiochemical detection. The effect of chronic intraperitoneal (i.p.) administration of the NOS inhibitor
N
G-nitro-
l-arginine methyl ester (
l-NAME, 50 mg/kg/day) on energy intake, bodyweight and hypothalamic nitric oxide content was assessed in both chow-fed and DIO animals. Twenty-four hour energy intake after acute intracerebroventricular (i.c.v.) of
l-NME was also measured. Diet-induced obese animals had a statistically significant 32% reduction in the number of nNOS-immunolabelled cells in the ventromedial hypothalamus compared to chow-fed controls. Intraperitoneal administration of
l-NAME decreased hypothalamic NO content in both chow-fed and DIO. Energy intake was reduced by 16% in DIO over 16 days, whereas energy intake was only reduced by 11% in chow-fed animals, although both were statistically significant.
l-NAME significantly reduced body weight gain in DIO but not in chow-fed rats.
l-NAME administered i.c.v. decreased 24 h energy intake to a greater extent in DIO rats, by 18%, compared with a 10% reduction in chow-fed rats. Ventromedial hypothalamic expression of nNOS is sensitive to changes in nutritional state. Despite having reduced nNOS, dietary obese rats were more sensitive to the effects of NOS inhibition than lean controls, suggesting a role for NO in the development of hyperphagia and obesity in rats fed a palatable diet.</description><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Cell Count - methods</subject><subject>Diet</subject><subject>Energy balance</subject><subject>Energy Intake - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Hypothalamus</subject><subject>Immunohistochemistry - methods</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - physiology</subject><subject>Nitric Oxide Synthase - antagonists & inhibitors</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Nitric Oxide Synthase Type I</subject><subject>Obesity</subject><subject>Obesity - chemically induced</subject><subject>Obesity - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Ventromedial Hypothalamic Nucleus - drug effects</subject><subject>Ventromedial Hypothalamic Nucleus - enzymology</subject><subject>Ventromedial Hypothalamic Nucleus - metabolism</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2P0zAQhiMEYsvCX1j5ArcWO04chxNoxZe0YiU-zpZjT7auUruMnWr7O_lDTGkRcMIXe-znnRnPW1VXgq8EF-rlZjWgDREhr2rOmxVvV5x3D6qF0F29VHXDH1YLzrla6r6XF9WTnDcUStnzx9WFaOtG6VYvqh-fwc8OPNtDLJi24IOd2PqwS2VtJ7sNjkWYMUW6jaEgxek-eGD5EInIwGz0LESHQIFnGWIOJexDObCS2KfbL_S4DgPdpUhH5gMUiweWBiAx2pJfsXHGsgZksKfM0QFLI7MM0wRsTPhvXUpBLEO4myf7KynBEAHvDmygjkn-tHo02inDs_N-WX179_br9Yflze37j9dvbpauqduybKwctQIQXa9GMdS0YJQNWCld23eq862WetSyb3vVc-8bUK5pauWtE60U8rJ6ccq7w_R9hlzMNmQHEzUBac5GdLrmWhxBdQIdppwRRrPDsKUpGMHN0U6zMb_tNEc7DW8N2UnCq3OFeSBr_sjO_hHw_AzY7Ow0Iv0_5L-4vm1qLYl7feKA5rEPgCa7cBy1DwiuGJ_C_3r5CSEIxu8</recordid><startdate>20040806</startdate><enddate>20040806</enddate><creator>Sadler, C.J</creator><creator>Wilding, J.P.H</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20040806</creationdate><title>Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balance</title><author>Sadler, C.J ; Wilding, J.P.H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-4a3f86ee1796f1b2222ef34ea33c59767d5838f83959690dd4e6c4426dac15313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Cell Count - methods</topic><topic>Diet</topic><topic>Energy balance</topic><topic>Energy Intake - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Hypothalamus</topic><topic>Immunohistochemistry - methods</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - physiology</topic><topic>Nitric Oxide Synthase - antagonists & inhibitors</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Nitric Oxide Synthase Type I</topic><topic>Obesity</topic><topic>Obesity - chemically induced</topic><topic>Obesity - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Ventromedial Hypothalamic Nucleus - drug effects</topic><topic>Ventromedial Hypothalamic Nucleus - enzymology</topic><topic>Ventromedial Hypothalamic Nucleus - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sadler, C.J</creatorcontrib><creatorcontrib>Wilding, J.P.H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sadler, C.J</au><au>Wilding, J.P.H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balance</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>2004-08-06</date><risdate>2004</risdate><volume>1016</volume><issue>2</issue><spage>222</spage><epage>228</epage><pages>222-228</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Inhibition of hypothalamic nitric oxide (NO) decreases energy intake, and changes in hypothalamic NO synthase (NOS) have been observed in genetically obese rodents, but it is not known if NO is involved in the development of diet-induced obesity (DIO). We therefore measured changes in hypothalamic neuronal NOS (nNOS) in DIO and investigated effects of peripheral and central inhibition of NOS in this model. Expression of nNOS in relation to changes in nutritional state was measured by immunohistochemistry, with radiochemical detection. The effect of chronic intraperitoneal (i.p.) administration of the NOS inhibitor
N
G-nitro-
l-arginine methyl ester (
l-NAME, 50 mg/kg/day) on energy intake, bodyweight and hypothalamic nitric oxide content was assessed in both chow-fed and DIO animals. Twenty-four hour energy intake after acute intracerebroventricular (i.c.v.) of
l-NME was also measured. Diet-induced obese animals had a statistically significant 32% reduction in the number of nNOS-immunolabelled cells in the ventromedial hypothalamus compared to chow-fed controls. Intraperitoneal administration of
l-NAME decreased hypothalamic NO content in both chow-fed and DIO. Energy intake was reduced by 16% in DIO over 16 days, whereas energy intake was only reduced by 11% in chow-fed animals, although both were statistically significant.
l-NAME significantly reduced body weight gain in DIO but not in chow-fed rats.
l-NAME administered i.c.v. decreased 24 h energy intake to a greater extent in DIO rats, by 18%, compared with a 10% reduction in chow-fed rats. Ventromedial hypothalamic expression of nNOS is sensitive to changes in nutritional state. Despite having reduced nNOS, dietary obese rats were more sensitive to the effects of NOS inhibition than lean controls, suggesting a role for NO in the development of hyperphagia and obesity in rats fed a palatable diet.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>15246858</pmid><doi>10.1016/j.brainres.2004.05.007</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-8993 |
ispartof | Brain research, 2004-08, Vol.1016 (2), p.222-228 |
issn | 0006-8993 1872-6240 |
language | eng |
recordid | cdi_proquest_miscellaneous_17820811 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Analysis of Variance Animals Biological and medical sciences Body Weight - drug effects Cell Count - methods Diet Energy balance Energy Intake - drug effects Enzyme Inhibitors - pharmacology Hypothalamus Immunohistochemistry - methods Male Medical sciences Metabolic diseases NG-Nitroarginine Methyl Ester - pharmacology Nitric oxide Nitric Oxide - physiology Nitric Oxide Synthase - antagonists & inhibitors Nitric Oxide Synthase - metabolism Nitric Oxide Synthase Type I Obesity Obesity - chemically induced Obesity - metabolism Rats Rats, Wistar Ventromedial Hypothalamic Nucleus - drug effects Ventromedial Hypothalamic Nucleus - enzymology Ventromedial Hypothalamic Nucleus - metabolism |
title | Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balance |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T07%3A50%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20ventromedial%20hypothalamic%20neuronal%20nitric%20oxide%20synthase%20and%20increased%20sensitivity%20to%20NOS%20inhibition%20in%20dietary%20obese%20rats:%20further%20evidence%20of%20a%20role%20for%20nitric%20oxide%20in%20the%20regulation%20of%20energy%20balance&rft.jtitle=Brain%20research&rft.au=Sadler,%20C.J&rft.date=2004-08-06&rft.volume=1016&rft.issue=2&rft.spage=222&rft.epage=228&rft.pages=222-228&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/j.brainres.2004.05.007&rft_dat=%3Cproquest_cross%3E17820811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17820811&rft_id=info:pmid/15246858&rft_els_id=S0006899304007309&rfr_iscdi=true |